Stockscreener 앱 받기
2.175
0.68%
-0.015
시간 외 거래:
2.18
0.005
+0.23%
Xortx Therapeutics Inc 주식(XRTX)의 최신 뉴스
XORTX Therapeutics appoints Mika Grasso as co‑CEO - MSN
XORTX Therapeutics Appoints Mika Grasso as Co-CEO; Voluntarily Delisting from the TSX Venture Exchange - marketscreener.com
XORTX Therapeutics Inc. Announces Appointment of Mika Grasso to Co-CEO - marketscreener.com
XORTX Therapeutics Providing Corporate Update and Appoints Mika Grasso as Co-CEO - marketscreener.com
XORTX Therapeutics (NASDAQ: XRTX) refocuses on gout program and appoints co-CEO - Stock Titan
A 28-year-old co-CEO and XORTX's $700M gout push in the US - Stock Titan
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange - The Manila Times
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange | Associated Press | syndication news - Enidnews.com
XORTX Therapeutics (NASDAQ: XRTX) to voluntarily delist from TSX Venture - Stock Titan
XORTX drops TSX Venture listing to reduce costs, focus on gout drug - Stock Titan
XORTX Therapeutics Company Profile & Introduction - Moomoo
XRTX Stock Chart | XORTX THERAPEUTICS INC (NASDAQ:XRTX) - ChartMill
XORTX Therapeutics (XRTX) Slides Over 3% as Biotech Stock Tests Key Support LevelsBreakout Stock Alerts - newsline.com
XORTX Therapeutics (XRTX) Holds Near Support in Quiet Trading SessionSkew Index - thelegaladvocate.com
XORTX Therapeutics (XRTX) Edges Higher as Stock Holds Above Key SupportAnalyst Upgrade Stocks - newsline.com
XORTX Therapeutics (XRTX) Gains 1.27% as Shares Test Key Resistance LevelFund Manager Survey - newsline.com
XRTX News | XORTX THERAPEUTICS INC (NASDAQ:XRTX) - ChartMill
XORTX Therapeutics Q1 2024 Earnings: Steep EPS Miss Highlights Pre‑Revenue Biotech HurdlesGuidance Upgrade Report - newsline.com
XORTX Therapeutics Raises US$5 Million Via Public Offering - marketscreener.com
XORTX Announces Closing of US$5 Million Public Offering - markets.businessinsider.com
XORTX Therapeutics (NASDAQ: XRTX) closes US$5M share and pre-funded warrant deal - Stock Titan
XORTX raises US$5M, earmarks US$2.5M for investor marketing - Stock Titan
E.F. Hutton & Co. Serves as Exclusive Placement Agent on XORTX Therapeutics Inc. $5 Million Public Offering - The Manila Times
XORTX Therapeutics Inc.Common Shares (NQ: XRTX - FinancialContent
XORTX Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
XORTX Therapeutics Inc expected to post a loss of C$1.64 a shareEarnings Preview - TradingView
Here are the top movers in Friday's session. - ChartMill
XORTX (NASDAQ: XRTX) raises ~$4.7M via share sale and pre-funded warrants - Stock Titan
XRTX Announces Public Offering of Shares - GuruFocus
XORTX Therapeutics Raising US$5 Million in a Public Offering; Shares Down 8.9% - marketscreener.com
XORTX (NASDAQ: XRTX) prices US$5M public equity and warrant deal - Stock Titan
Xortx announces US$5 million public offering - marketscreener.com
XORTX Announces US$5 Million Public Offering - The Manila Times
XORTX Announces US$5 Million Public Offering | Associated Press | syndication news - Enidnews.com
[EFFECT] XORTX Therapeutics Inc. SEC Filing - Stock Titan
Kidney drug developer XORTX prices US$5M Nasdaq share sale - Stock Titan
XORTX Says Preliminary Equity Levels Meet Nasdaq Listing Threshold - The Globe and Mail
XORTX (NASDAQ: XRTX) estimates $4.1M equity, above Nasdaq minimum - Stock Titan
1.8M-share offering — XORTX Therapeutics (NASDAQ: XRTX) files F-1 amendment - Stock Titan
XRTX XORTX Therapeutics posts far wider Q1 2024 loss than estimates, shares fall 1.85% amid elevated RD spending.Balance Sheet - newser.com
XORTX shareholders approve up-to-5-for-1 share consolidation to meet Nasdaq rules - MSN
XORTX Therapeutics (XRTX) Stock: Pricing Efficiency Review | Q1 2024: Earnings Fall ShortAnalyst Recommended Stocks - Newser
XORTX Therapeutics (NASDAQ: XRTX) registers up to 2.2M shares; $4.7M estimated proceeds - Stock Titan
XORTX Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filingmoomoo - Moomoo
1.27%
1.43%
자본화:
|
볼륨(24시간):